» Articles » PMID: 37232729

The Effect of Probiotic Supplementation on the Gut-Brain Axis in Psychiatric Patients

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2023 May 26
PMID 37232729
Authors
Affiliations
Soon will be listed here.
Abstract

The pathophysiology of several psychiatric diseases may entail disturbances in the hypothalamic-pituitary-adrenal (HPA) axis and metabolic pathways. Variations in how these effects present themselves may be connected to individual variances in clinical symptoms and treatment responses, such as the observation that a significant fraction of participants do not respond to current antipsychotic drugs. A bidirectional signaling pathway between the central nervous system and the gastrointestinal tract is known as the microbiota-gut-brain axis. The large and small intestines contain more than 100 trillion microbial cells, contributing to the intestinal ecosystem's incredible complexity. Interactions between the microbiota and intestinal epithelium can alter brain physiology and affect mood and behavior. There has recently been a focus on how these relationships impact mental health. According to evidence, intestinal microbiota may play a role in neurological and mental illnesses. Intestinal metabolites of microbial origin, such as short-chain fatty acids, tryptophan metabolites, and bacterial components that might stimulate the host's immune system, are mentioned in this review. We aim to shed some on the growing role of gut microbiota in inducing/manipulating several psychiatric disorders, which may pave the way for novel microbiota-based therapies.

Citing Articles

Limited Changes in Red Blood Cell Parameters After Probiotic Supplementation in Depressive Individuals: Insights from a Secondary Analysis of the PRO-DEMET Randomized Controlled Trial.

Gajewska A, Wysokinski A, Strzelecki D, Gawlik-Kotelnicka O J Clin Med. 2025; 14(1.

PMID: 39797347 PMC: 11721667. DOI: 10.3390/jcm14010265.


Neuroprotective effect of Bacillus subtilis in haloperidol induced rat model, targeting the microbiota-gut-brain axis.

Rout M, Kar D, Dubey D, Kispotta S, Sarangi P, Prusty S J Mol Histol. 2024; 56(1):18.

PMID: 39625518 DOI: 10.1007/s10735-024-10307-0.


Strain-specific effects of probiotics on depression and anxiety: a meta-analysis.

Rahmannia M, Poudineh M, Mirzaei R, Aalipour M, Shahidi Bonjar A, Goudarzi M Gut Pathog. 2024; 16(1):46.

PMID: 39245752 PMC: 11382490. DOI: 10.1186/s13099-024-00634-8.


Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Nissle 1917 strain.

Falzone L, Lavoro A, Candido S, Salmeri M, Zanghi A, Libra M Gut Microbes. 2024; 16(1):2397874.

PMID: 39229962 PMC: 11376418. DOI: 10.1080/19490976.2024.2397874.


Probiotic Functions in Fermented Foods: Anti-Viral, Immunomodulatory, and Anti-Cancer Benefits.

Pyo Y, Kwon K, Jung Y Foods. 2024; 13(15).

PMID: 39123577 PMC: 11311591. DOI: 10.3390/foods13152386.


References
1.
Taylor A, Holscher H . A review of dietary and microbial connections to depression, anxiety, and stress. Nutr Neurosci. 2018; 23(3):237-250. DOI: 10.1080/1028415X.2018.1493808. View

2.
Ilie O, Ciobica A, McKenna J, Doroftei B, Mavroudis I . Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxid Med Cell Longev. 2020; 2020:4518023. PMC: 7025076. DOI: 10.1155/2020/4518023. View

3.
Morkl S, Butler M, Holl A, Cryan J, Dinan T . Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry. Curr Nutr Rep. 2020; 9(3):171-182. PMC: 7398953. DOI: 10.1007/s13668-020-00313-5. View

4.
Gondalia S, Parkinson L, Stough C, Scholey A . Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy. Psychopharmacology (Berl). 2019; 236(5):1433-1443. DOI: 10.1007/s00213-019-05248-6. View

5.
Witusik A, Pietras T . Music therapy as a complementary form of therapy for mental disorders. Pol Merkur Lekarski. 2020; 47(282):240-243. View